Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Hirons

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Lancet. Infectious Diseases|September 28, 2020
Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silentAshley Hirons, Georges Khoury, Damian F J Purcell
Retrovirology|July 16, 2024
High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central AustraliaAshley Hirons, David Yurick, Natasha Jansz, et al.
Viruses|October 26, 2024
Current State of Therapeutics for HTLV-1Tiana T Wang, Ashley Hirons, Marcel Doerflinger, et al.
Viruses|April 27, 2026
Common Acquisition of Broadly Neutralizing Antibodies in an HTLV-1c+ First Nations Cohort from Central AustraliaSamantha L Grimley, Sarah C Monard, Ashley Hirons, et al.
Cell|July 11, 2025
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivoJames P Cooney, Ashley Hirons, Natasha Jansz, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Lancet. Infectious Diseases|September 28, 2020
Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silentAshley Hirons, Georges Khoury, Damian F J Purcell
Retrovirology|July 16, 2024
High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central AustraliaAshley Hirons, David Yurick, Natasha Jansz, et al.
Viruses|October 26, 2024
Current State of Therapeutics for HTLV-1Tiana T Wang, Ashley Hirons, Marcel Doerflinger, et al.
Viruses|April 27, 2026
Common Acquisition of Broadly Neutralizing Antibodies in an HTLV-1c+ First Nations Cohort from Central AustraliaSamantha L Grimley, Sarah C Monard, Ashley Hirons, et al.
Cell|July 11, 2025
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivoJames P Cooney, Ashley Hirons, Natasha Jansz, et al.
Pageof 1